Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 95,867 $ 113,915
Accounts receivable 5,431 7,758
Short-term investments (certificates of deposit) 22,538 36,002
Cash deposits with clearing organizations 336 1,041
Receivables from broker-dealers and clearing organizations 11,884 7,395
Forgivable loans receivable 1,610 1,616
Securities owned, at fair value 6,675 1,985
Inventory 674 171
Other receivables - related party 414 618
Prepaid expenses and other current assets 14,089 12,680
Total current assets 159,518 183,181
Property and equipment, net 14,642 9,513
Restricted cash 17,358 17,387
Long-term investments, at fair value 0 1,390
Intangible assets 13,935 15,223
Goodwill 18,645 18,645
Other assets 821 611
Total assets 224,919 245,950
Current liabilities    
Accounts payable and accrued expenses 37,345 36,127
Accounts payable and accrued expenses - related party 153 222
Accrued commissions and payroll payable 11,974 10,065
Deferred clearing and marketing credits 629 786
Securities sold, not yet purchased, at fair value 24 151
Warrants issued - National 0 5,597
Interest payable 613 887
Interest payable - related party 94 97
Notes payable, short-term (net of debt discount of $447 and $973 at September 30, 2018 and December 31, 2017, respectively) 9,054 8,528
Subsidiary convertible note, short-term, at fair value 10,657 4,700
Deferred revenue 155 0
Derivative warrant liability 0 87
Other current liabilities 77 181
Total current liabilities 70,775 67,428
Notes payable, long-term (net of debt discount of $445 and $62 at September 30, 2018 and December 31, 2017, respectively) 64,546 43,222
Subsidiary convertible note, long-term, at fair value 0 10,059
Other long-term liabilities 4,961 4,739
Total liabilities 140,282 125,448
Stockholders' equity    
Preferred stock, $0.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 1,000,000 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively; liquidation value of $25.00 per share 1 1
Common stock, $0.001 par value, 100,000,000 shares authorized, 56,183,480 and 50,991,285 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 56 51
Common stock issuable, 347,684 and 158,015 shares as of September 30, 2018 and December 31, 2017, respectively 495 500
Additional paid-in-capital 408,615 364,148
Accumulated deficit (371,394) (312,127)
Total stockholders' equity attributed to the Company 37,773 52,573
Non-controlling interests 46,864 67,929
Total stockholders' equity 84,637 120,502
Total liabilities and stockholders' equity $ 224,919 $ 245,950